申请人:Synta Pharmaceuticals Corp.
公开号:US20130303542A1
公开(公告)日:2013-11-14
The invention relates to certain compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
本发明涉及某些化合物,或其药学上可接受的盐,溶剂合物,笼合物或前药,其作为免疫抑制剂和治疗和预防炎症状况,过敏性疾病和免疫疾病有用。